Upload
xander-hebert
View
29
Download
2
Embed Size (px)
DESCRIPTION
Epidemiologic trends in HIV infection among men who have sex with men in Ontario: The situation in 2004. Robert S. Remis, Maraki Fikre Merid Ontario HIV Epidemiologic Monitoring Unit Department of Public Health Sciences University of Toronto Gay Men’s HIV Prevention Working Group - PowerPoint PPT Presentation
Citation preview
Epidemiologic trends inEpidemiologic trends inHIV infection among men who HIV infection among men who have sex with men in Ontario: have sex with men in Ontario:
The situation in 2004The situation in 2004
Robert S. Remis, Maraki Fikre MeridRobert S. Remis, Maraki Fikre Merid
Ontario HIV Epidemiologic Monitoring UnitOntario HIV Epidemiologic Monitoring Unit
Department of Public Health SciencesDepartment of Public Health Sciences
University of TorontoUniversity of Toronto
Gay Men’s HIV Prevention Working GroupGay Men’s HIV Prevention Working Group
Toronto, Ontario, November 18, 2004Toronto, Ontario, November 18, 2004
MOHLTC, Laboratories Branch, IMC – 2001
BackgroundBackground
• MSM seriously affected by HIV epidemic MSM seriously affected by HIV epidemic since the beginning (late 1970s)since the beginning (late 1970s)
• Many developments have influenced Many developments have influenced trends in the epidemic since then:trends in the epidemic since then:
Education, information and preventionEducation, information and preventionIdentification of HIV in 1984Identification of HIV in 1984HIV test developed late 1985HIV test developed late 1985Antiretroviral drugs, 1987-95Antiretroviral drugs, 1987-95HAART 1996-HAART 1996-
MOHLTC, Laboratories Branch, IMC – 2001
ObjectiveObjective
• To examine trends in incidence and To examine trends in incidence and prevalence of HIV infection among MSM prevalence of HIV infection among MSM in Ontarioin Ontario
MOHLTC, Laboratories Branch, IMC – 2001
Methods: Data sourcesMethods: Data sources
• HIV diagnostic data HIV diagnostic data • Laboratory Enhancement Study Laboratory Enhancement Study • Detuned assayDetuned assay• Repeat testersRepeat testers• Reported AIDS casesReported AIDS cases• HIV-related mortalityHIV-related mortality
MOHLTC, Laboratories Branch, IMC – 2001
Methods: Data analysisMethods: Data analysis
• HIV model: Incidence and prevalence ofHIV model: Incidence and prevalence of• HIV infectionHIV infection• HIV diagnosesHIV diagnoses• AIDSAIDS• HIV-related mortalityHIV-related mortality
Dr. Robert S. RemisPublic Health Sciences, University of Toronto
MOHLTC, Laboratories Branch, IMC – 2001
Reported AIDS cases by Reported AIDS cases by exposure category and exposure category and sex,1981-2003sex,1981-2003
Males Females TotalNo. % No. % No. %
MSM 5,258 78.3% 0 0.0% 5,258 72.6%MSM-IDU 299 4.5% 0 0.0% 299 4.1%IDU 258 3.8% 78 14.8% 336 4.6%HIV-endemic 260 3.9% 156 29.6% 416 5.7%Heterosexual 414 6.2% 204 38.7% 618 8.5%Clotting factor 100 1.5% 10 1.9% 110 1.5%Transfusion 94 1.4% 49 9.3% 143 2.0%Perinatal 26 0.4% 29 5.5% 55 0.8%Occupational 6 0.1% 1 0.2% 7 0.1%NIR 248 24 272Total 6,963 100.0% 551 100.0% 7,514 100.0%
* Proportion EC known = 96.4%
MOHLTC, Laboratories Branch, IMC – 2001
Reported AIDS cases for selected Reported AIDS cases for selected exposure categories, 1981-2003exposure categories, 1981-2003
0
100
200
300
400
500
600
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
Year of AIDS diagnosis
Nu
mb
er
of
ca
se
s (
ad
jus
ted
)
MSM
MSM-IDU
Other known
MOHLTC, Laboratories Branch, IMC – 2001
First-time HIV diagnoses (adjusted) for First-time HIV diagnoses (adjusted) for selected exposure categories,1985-selected exposure categories,1985-20032003
0
200
400
600
800
1,000
1,200
1,400
1,600
1,800
Year of HIV diagnosis
Nu
mb
er
of
ne
w d
iag
no
se
s (
ad
jus
ted
)
MSM
MSM-IDU
Other exp
MOHLTC, Laboratories Branch, IMC – 2001
HIV diagnoses (adjusted) by exposure HIV diagnoses (adjusted) by exposure category and gender, Ontario 1985-category and gender, Ontario 1985-20032003
Males Females Total
MSM 16,382 76.8% 0 0.0% 16,382 66.2%MSM-IDU 973 4.6% 0 0.0% 973 3.9%IDU 1,410 6.6% 600 17.6% 2,010 8.1%Clotting factor 271 1.3% 37 1.1% 307 1.2%Transfusion 212 1.0% 182 5.3% 394 1.6%HIV-endemic 901 4.2% 1,120 32.9% 2,021 8.2%HR hetero 180 0.8% 683 20.0% 863 3.5%LR hetero 755 3.5% 559 16.4% 1,314 5.3%Perinatal2 175 0.8% 164 4.8% 339 1.4%Other 67 0.3% 64 1.9% 131 0.5%Total 21,325 100.0% 3,409 100.0% 24,734 100.0%
MOHLTC, Laboratories Branch, IMC – 2001
First-time HIV diagnoses among MSM First-time HIV diagnoses among MSM by health region, 1985-2003by health region, 1985-2003
Number Proportion RateToronto 12,293 75.0% 1,028.6Ottawa 1,238 7.6% 339.3Southwest 1,162 7.1% 158.8Eastern, other 232 1.4% 59.9Central West 668 4.1% 63.9Northern 179 1.1% 39.5Central East, other 608 3.7% 47.0
Total 16,382 100.0% 299.5
MOHLTC, Laboratories Branch, IMC – 2001
Number first-time HIV diagnoses, MSM Number first-time HIV diagnoses, MSM selected health regions, 1999–2004selected health regions, 1999–2004
0
20
40
60
80
100
1999 2000 2001 2002 2003 2004
Nu
mb
er
of
ca
se
s
NorthernOttawaEasternC EastC WestSouthwest
MOHLTC, Laboratories Branch, IMC – 2001
Number first-time HIV diagnoses, Number first-time HIV diagnoses, MSM, Toronto, 1999–2004MSM, Toronto, 1999–2004
0
100
200
300
400
500
1999 2000 2001 2002 2003 2004
Nu
mb
er
of
ca
se
s
Toronto
MOHLTC, Laboratories Branch, IMC – 2001
HIV incidence among MSM repeat testers, HIV incidence among MSM repeat testers,
with 95% CLs, 1992-2002 (37,711 PY)with 95% CLs, 1992-2002 (37,711 PY)
0.75
0.94 0.88
1.13
0.870.97
1.5
0.0
0.5
1.0
1.5
2.0
2.5
1996 1997 1998 1999 2000 2001 2002
Year
Ser
oco
nve
rsio
ns
per
100
PY
Source: Polaris Seroconversion Study
MOHLTC, Laboratories Branch, IMC – 2001
Measured and adjusted HIV incidence, Measured and adjusted HIV incidence, MSM by health region,1999 – 2003MSM by health region,1999 – 2003
1.94
2.28
1.71
2.01
0.670.78
1.51
1.77
0.0
1.0
2.0
3.0
HIV
inci
den
ce p
er 1
00 P
Y
Toronto Ottawa Other Ontario
Source: Laboratory Enhancement Study
MOHLTC, Laboratories Branch, IMC – 2001
Measured and adjusted HIV Measured and adjusted HIV incidence,MSM, Ontario, 1999 – incidence,MSM, Ontario, 1999 – 20032003
0.0
0.5
1.0
1.5
2.0
2.5
3.0
1999 2000 2001 2002 2003
Inc
ide
nc
e d
en
sit
y (
/10
0 p
-y)
ID measuredID adjusted
Source: Laboratory Enhancement Study
MOHLTC, Laboratories Branch, IMC – 2001
Measured and adjusted HIV Measured and adjusted HIV incidence MSM, Toronto, 1999 – incidence MSM, Toronto, 1999 – 20032003
0.0
0.5
1.0
1.5
2.0
2.5
3.0
1999 2000 2001 2002 2003
Inc
ide
nc
e d
en
sit
y (
/10
0 p
-y)
ID measuredID adjusted
Source: Laboratory Enhancement Study
MOHLTC, Laboratories Branch, IMC – 2001
Measured and adjusted HIV Measured and adjusted HIV incidence MSM, Ottawa, 1999 – incidence MSM, Ottawa, 1999 – 20032003
0.0
0.5
1.0
1.5
2.0
2.5
3.0
1999 2000 2001 2002 2003
Inc
ide
nc
e d
en
sit
y (
/10
0 p
-y)
ID measuredID adjusted
Source: Laboratory Enhancement Study
MOHLTC, Laboratories Branch, IMC – 2001
Measured and adjusted HIV Measured and adjusted HIV incidence, MSM, Ontario, 1999 – 2003incidence, MSM, Ontario, 1999 – 2003
0.0
0.5
1.0
1.5
2.0
2.5
3.0
1999 2000 2001 2002 2003
Inc
ide
nc
e d
en
sit
y (
/10
0 p
-y)
ID measuredID adjusted
Source: Laboratory Enhancement Study
MOHLTC, Laboratories Branch, IMC – 2001
Modeled HIV prevalence by Modeled HIV prevalence by exposure category, Ontario,exposure category, Ontario,December 2003December 2003
Proportion Number ProportionHIV diagnosed HIV Ontario
prevalence living undiagnosed undiagnosed
MSM 14,370 68.9% 4,278 51.9%MSM-IDU 703 58.1% 262 3.2%IDU 1,959 67.0% 644 7.8%Endemic 3,011 47.5% 1,481 18.0%Hetero 3,311 50.5% 1,557 18.9%Clotting 156 99.5% 3 0.0%Transfusion 41 77.0% 10 0.1%
23,552 63.3% 8,236 100.0%
MOHLTC, Laboratories Branch, IMC – 2001
Modeled HIV incidence among MSMModeled HIV incidence among MSMOntario, 1977–2003Ontario, 1977–2003
0.0%
0.5%
1.0%
1.5%
2.0%
2.5%
3.0%
1977 1979 1981 1983 1985 1987 1989 1991 1993 1995 1997 1999 2001 2003Year
An
nu
al i
nc
ide
nc
e r
ate
0
200
400
600
800
1,000
1,200
1,400
1,600
1,800
Nu
mb
er
of
ne
w in
fec
tio
ns
Incidence rate
Incidence number
Dr. Robert S. RemisPublic Health Sciences, University of Toronto
MOHLTC, Laboratories Branch, IMC – 2001
Modeled HIV prevalence among Modeled HIV prevalence among MSM, Ontario, 1977–2003MSM, Ontario, 1977–2003
0%
2%
4%
6%
8%
10%
12%
14%
16%
18%
1977
1979
1981
1983
1985
1987
1989
1991
1993
1995
1997
1999
2001
2003Year
Pro
po
rtio
n H
IV in
fec
ted
0
2,000
4,000
6,000
8,000
10,000
12,000
14,000
16,000
Nu
mb
er
of
HIV
-in
fec
ted
me
n
Prevalence %
Prevalence number
Dr. Robert S. RemisPublic Health Sciences, University of Toronto
MOHLTC, Laboratories Branch, IMC – 2001
ConclusionsConclusions
• Gay men in Ontario continue to be severely Gay men in Ontario continue to be severely affected by the HIV epidemicaffected by the HIV epidemic
• Remains most important groupRemains most important group• 14,400 MSM HIV-infected14,400 MSM HIV-infected• HIV prevalence: ~16% (varies regionally, 10-HIV prevalence: ~16% (varies regionally, 10-
20%)20%)• Past 5 years, Increase in MSM living with HIV Past 5 years, Increase in MSM living with HIV
infection 29%, 5.4% annuallyinfection 29%, 5.4% annually• HIV incidence (i.e. new infections) not HIV incidence (i.e. new infections) not
decreasing; increasing in Ottawadecreasing; increasing in Ottawa
MOHLTC, Laboratories Branch, IMC – 2001
ConclusionsConclusions
• Trends in risk behaviour elsewhere are Trends in risk behaviour elsewhere are consistent with trend in HIV incidenceconsistent with trend in HIV incidence
• Reasons for persisting high incidence unclear: Reasons for persisting high incidence unclear: treatment optimism? safe-sex fatigue?treatment optimism? safe-sex fatigue?
MOHLTC, Laboratories Branch, IMC – 2001
ConclusionsConclusions
• Observed increase in new HIV Observed increase in new HIV diagnoses in 2003 of particular diagnoses in 2003 of particular concernconcern
• May be due to: May be due to: • increased HIV testingincreased HIV testing
oror• increased HIV incidenceincreased HIV incidence
MOHLTC, Laboratories Branch, IMC – 2001
ConclusionsConclusions
• Likely due, at least in part, to increased Likely due, at least in part, to increased HIV incidence since:HIV incidence since:• increase in HIV+ tests > increase in increase in HIV+ tests > increase in
teststests• proportion identified as seroconverters proportion identified as seroconverters
by linked tests or serologic evidence is by linked tests or serologic evidence is stablestable
• incidence in repeat testers increasingincidence in repeat testers increasing• data from elsewhere and syphilis data from elsewhere and syphilis
epidemic evidence for increased risky epidemic evidence for increased risky sexual behavioursexual behaviour
MOHLTC, Laboratories Branch, IMC – 2001
AcknowledgementsAcknowledgements
AIDS Bureau, AIDS Bureau, Ontario Ministry of Health and Long-Term Ontario Ministry of Health and Long-Term CareCare
• Frank McGee, coordinatorFrank McGee, coordinator• HIV Laboratory, Central Public Health LaboratoryHIV Laboratory, Central Public Health Laboratory
• Carol Swantee, diagnostic dataCarol Swantee, diagnostic data• Keyi Wu, programmingKeyi Wu, programming• Jane NjihiaJane Njihia
• Laboratory Enhancement StudyLaboratory Enhancement Study• Chris Archibald, CIDPC, Health CanadaChris Archibald, CIDPC, Health Canada• Ontario HIV Treatment NetworkOntario HIV Treatment Network